Timo Minssen

Professor

JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- timo.minssen@jur.ku.dk
- https://jura.ku.dk/cebil/staff/profile/?pure=en/persons/381631
Mobil: +46708607517

ORCID: 0000-0002-3286-4888

Alle

341 - 350 ud af 413Pr. side: 10

Sortering: Type

Foredrag og mundtlige bidrag
The legal ecology of resistance, or why normal IP rules should not apply to antibiotics- An IP seminar at the University of Oxford
Minssen, Timo (Oplægsholder)
25 apr. 2014
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
The legal method of "Law & Technology"
Minssen, Timo (Foredragsholder)
6 jun. 2013
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
The new Centre for Advanced Studies in Biomedical Innovation Law (CeBIL): Where we come from - What we do - Where we want to go.
Minssen, Timo (Oplægsholder) & Wested, Jakob (Oplægsholder)
25 maj 2018
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
The patent eligibility of human embryonic stem cell technology in Europe
Minssen, Timo (Foredragsholder)
13 aug. 2012
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
The patent eligibility of human embryonic stem cell technology in Europe - What happened after Brüstle?
Minssen, Timo (Foredragsholder)
12 aug. 2013
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
The patentability of personalized medicine in Europe - Dosage regimes and genetic diagnostic methods
Minssen, Timo (Foredragsholder)
13 aug. 2012
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
U.S. regulation and patentability of human embryonic stem cell research
Minssen, Timo (Oplægsholder)
21 mar. 2012
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
US decisions in Sequenom Inc v Ariosa Diagnostics Inc- What now?: University of Cambridge (UK)
Minssen, Timo (Inviteret foredragsholder)
6 sep. 2016
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
Utility Model Protection in Danish Law at LSE
Minssen, Timo (Andet)
2 feb. 2023
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
WHO panel on the governance of gene editing
Minssen, Timo (Andet)
2021
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag

Forrige 1...31 32 33 34 35 36 37 38 ...42 Næste

ID: 16150437

Det Juridiske Fakultet

Timo Minssen

JUR Center for Advanced Studies in Bioscience Innovation Law

The legal ecology of resistance, or why normal IP rules should not apply to antibiotics- An IP seminar at the University of Oxford

The legal method of "Law & Technology"

The new Centre for Advanced Studies in Biomedical Innovation Law (CeBIL): Where we come from - What we do - Where we want to go.

The patent eligibility of human embryonic stem cell technology in Europe

The patent eligibility of human embryonic stem cell technology in Europe - What happened after Brüstle?

The patentability of personalized medicine in Europe - Dosage regimes and genetic diagnostic methods

U.S. regulation and patentability of human embryonic stem cell research

US decisions in Sequenom Inc v Ariosa Diagnostics Inc- What now?: University of Cambridge (UK)

Utility Model Protection in Danish Law at LSE

WHO panel on the governance of gene editing

Flest downloads

När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa

The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.

När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa